Content :
The GroupLatest press releaseApril 30, 2008 Encouraging first-quarter 2008 results - Further positive Phase III results for eplivanserin
Focus on the GroupFebruary 12, 2008 2007 earnings ahead of guidanceSharp rise in proposed dividend Corporate video clipThis corporate video presents our R&D, our therapeutic areas as well as our key figures. Clip - Solidarity at the heart of our actionsOur commitment in action: Protecting the health of patientsA major element of our commitment is ensuring the quality of our products. In addition to exacting manufacturing standards, sanofi-aventis also combats counterfeit imitation of its medicines. PublicationsMay 3, 2007 Annual Report 2006
May 3, 2007 Sustainable Development Report 2006
|
Slots : |